The roles of ADIPOQ genetic variations in cancer risk: Evidence from published studies

Molecular Biology Reports

Volumn 40, Issue 2, 2013, Pages 1135-1144

  Xu, Yeqiong ^a   He, Bangshun ^a   Pan, Yuqin ^a   Gu, Ling ^a   Nie, Zhenlin ^a   Chen, Liping ^a   Li, Rui ^a   Gao, Tianyi ^a   Wang, Shukui ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Adiponectin; ADIPOQ; Cancer risk; Genetic variation; Meta analysis; Polymorphism

Indexed keywords

ADIPONECTIN; FATTY ACID SYNTHASE;

ADIPOQ GENE; ARTICLE; BREAST CANCER; CANCER RISK; CARCINOGENESIS; CASE CONTROL STUDY; COLORECTAL CANCER; ETHNICITY; GENE; GENE FUNCTION; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HETEROZYGOSITY; HUMAN; NEOPLASM; PROSTATE CANCER; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW;

ADIPONECTIN; CASE-CONTROL STUDIES; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEOPLASMS; POLYMORPHISM, GENETIC; PUBLICATION BIAS; RISK;

EID: 84878371431     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-012-2154-2     Document Type: Article

References (29)

1. Pharoah PD, Dunning AM, Ponder BA, Easton DF (2004) Association studies for finding cancer-susceptibility genetic variants. Nat Rev Cancer 4(11):850-860. doi: 10.1038/nrc1476
2. Khandekar MJ, Cohen P, Spiegelman BM (2011) Molecular mechanisms of cancer development in obesity. Nat Rev Cancer 11(12):886-895. doi: 10.1038/nrc3174
3. Kadowaki T, Yamauchi T (2005) Adiponectin and adiponectin receptors. Endocr Rev 26(3):439-451. doi: 10.1210/er.2005-0005
4. Beebe-Dimmer JL, Zuhlke KA, Ray AM, Lange EM, Cooney KA (2010) Genetic variation in adiponectin (ADIPOQ) and the type 1 receptor (ADIPOR1), obesity and prostate cancer in African Americans. Prostate Cancer Prostatic Dis 13(4):362-368. doi: 10.1038/pcan.2010.27
5. Pechlivanis S, Bermejo JL, Pardini B, Naccarati A, Vodickova L, Novotny J, Hemminki K, Vodicka P, Forsti A (2009) Genetic variation in adipokine genes and risk of colorectal cancer. Eur J Endocrinol 160(6):933-940. doi: 10.1530/EJE-09-0039
6. Kaklamani VG, Wisinski KB, Sadim M, Gulden C, Do A, Offit K, Baron JA, Ahsan H, Mantzoros C, Pasche B (2008) Variants of the adiponectin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) genes and colorectal cancer risk. JAMA 300(13):1523-1531. doi: 10.1001/jama.300.13.1523
7. Partida-Perez M, de la Luz Ayala-Madrigal M, Peregrina-Sandoval J, Macias-Gomez N, Moreno-Ortiz J, Leal-Ugarte E, Cardenas-Meza M, Centeno-Flores M, Maciel-Gutierrez V, Cabrales E, Cervantes-Ortiz S, Gutierrez-Angulo M (2010) Association of LEP and ADIPOQ common variants with colorectal cancer in Mexican patients. Cancer Biomark 7(3):117-121. doi: 10.3233/CBM-2010-0154
8. He B, Pan Y, Zhang Y, Bao Q, Chen L, Nie Z, Gu L, Xu Y, Wang S (2011) Effects of genetic variations in the adiponectin pathway genes on the risk of colorectal cancer in the Chinese population. BMC Med Genet 12:94. doi: 10.1186/1471-2350-12-94
9. Yi N, Kaklamani VG, Pasche B (2011) Bayesian analysis of genetic interactions in case-control studies, with application to adiponectin genes and colorectal cancer risk. Ann Hum Genet 75(1):90-104. doi: 10.1111/j.1469-1809. 2010.00605.x
10. Kaklamani V, Yi N, Zhang K, Sadim M, Offit K, Oddoux C, Ostrer H, Mantzoros C, Pasche B (2011) Polymorphisms of ADIPOQ and ADIPOR1 and prostate cancer risk. Metabolism 60(9):1234-1243. doi: 10.1016/j.metabol.2011.01.005
11. Moore SC, Leitzmann MF, Albanes D, Weinstein SJ, Snyder K, Virtamo J, Ahn J, Mayne ST, Yu H, Peters U, Gunter MJ (2009) Adipokine genes and prostate cancer risk. Int J Cancer 124(4):869-876. doi: 10.1002/ijc.24043
12. Dhillon PK, Penney KL, Schumacher F, Rider JR, Sesso HD, Pollak M, Fiorentino M, Finn S, Loda M, Rifai N, Mucci LA, Giovannucci E, Stampfer MJ, Ma J (2011) Common polymorphisms in the adiponectin and its receptor genes, adiponectin levels and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 20(12):2618-2627. doi: 10.1158/1055-9965.EPI-11-0434
13. Kaklamani VG, Sadim M, Hsi A, Offit K, Oddoux C, Ostrer H, Ahsan H, Pasche B, Mantzoros C (2008) Variants of the adiponectin and adiponectin receptor 1 genes and breast cancer risk. Cancer Res 68(9):3178-3184. doi: 10.1158/0008-5472.CAN-08-0533
14. Teras LR, Goodman M, Patel AV, Bouzyk M, Tang W, Diver WR, Feigelson HS (2009) No association between polymorphisms in LEP, LEPR, ADIPOQ, ADIPOR1, or ADIPOR2 and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev 18(9):2553-2557. doi: 10.1158/1055-9965.EPI-09-0542
15. Wolk A, Gridley G, Svensson M, Nyren O, McLaughlin JK, Fraumeni JF, Adam HO (2001) A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control 12(1):13-21
16. Luo Z, Saha AK, Xiang X, Ruderman NB (2005) AMPK, the metabolic syndrome and cancer. Trends Pharmacol Sci 26(2):69-76. doi: 10.1016/j.tips.2004.12.011
17. Davis RJ (2000) Signal transduction by the JNK group of MAP kinases. Cell 103(2):239-252. doi: 10.1016/S0092-8674(00)00116-1
18. Handoll HH (2006) Systematic reviews on rehabilitation interventions. Arch Phys Med Rehabil 87(6):875. doi: 10.1016/j.apmr.2006.04.006
19. Midgette AS, Wong JB, Beshansky JR, Porath A, Fleming C, Pauker SG (1994) Cost-effectiveness of streptokinase for acute myocardial infarction: a combined meta-analysis and decision analysis of the effects of infarct location and of likelihood of infarction. Med Decis Making 14(2):108-117
20. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629-634
21. Cui E, Deng A, Wang X, Wang B, Mao W, Feng X, Hua F (2011) The role of adiponectin (ADIPOQ) gene polymorphisms in the susceptibility and prognosis of non-small cell lung cancer. Biochem Cell Biol 89(3):308-313. doi: 10.1139/o11-005
22. Qi L, Doria A, Manson JE, Meigs JB, Hunter D, Mantzoros CS, Hu FB (2006) Adiponectin genetic variability, plasma adiponectin, and cardiovascular risk in patients with type 2 diabetes. Diabetes 55(5):1512-1516
23. Heid IM, Wagner SA, Gohlke H, Iglseder B, Mueller JC, Cip P, Ladurner G, Reiter R, Stadlmayr A, Mackevics V, Illig T, Kronenberg F, Paulweber B (2006) Genetic architecture of the APM1 gene and its influence on adiponectin plasma levels and parameters of the metabolic syndrome in 1,727 healthy Caucasians. Diabetes 55(2):375-384
24. Gonzalez-Sanchez JL, Zabena CA, Martinez-Larrad MT, Fernandez-Perez C, Perez-Barba M, Laakso M, Serrano-Rios M (2005) An SNP in the adiponectin gene is associated with decreased serum adiponectin levels and risk for impaired glucose tolerance. Obes Res 13(5):807-812. doi: 10.1038/oby.2005.91
25. Fujisawa T, Endo H, Tomimoto A, Sugiyama M, Takahashi H, Saito S, Inamori M, Nakajima N, Watanabe M, Kubota N, Yamauchi T, Kadowaki T, Wada K, Nakagama H, Nakajima A (2008) Adiponectin suppresses colorectal carcinogenesis under the high-fat diet condition. Gut 57(11):1531-1538. doi: 10.1136/gut.2008.159293
26. Tilg H, Moschen AR (2006) Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 6(10):772-783. doi: 10.1038/nri1937
27. Al Khaldi RM, Al Mulla F, Al Awadhi S, Kapila K, Mojiminiyi OA (2011) Associations of single nucleotide polymorphisms in the adiponectin gene with adiponectin levels and cardio-metabolic risk factors in patients with cancer. Dis Markers 30(4):197-212. doi: 10.3233/DMA-2011-0775
28. Doecke JD, Zhao ZZ, Stark MS, Green AC, Hayward NK, Montgomery GW, Webb PM, Whiteman DC (2008) Single nucleotide polymorphisms in obesity-related genes and the risk of esophageal cancers. Cancer Epidemiol Biomarkers Prev 17(4):1007-1012. doi: 10.1158/1055-9965.EPI-08-0023
29. Carvajal-Carmona LG, Spain S, Kerr D, Houlston R, Cazier JB, Tomlinson I (2009) Common variation at the adiponectin locus is not associated with colorectal cancer risk in the UK. Hum Mol Genet 18(10):1889-1892. doi: 10.1093/hmg/ddp109